Enanta Pharmaceuticals, Inc. (ENTA)

11.64 +0.02 (+0.17%) USD  |  NASDAQ  |  Oct 23, 16:00
11.65 +0.01 (+0.09%) After-Hours: 20:00
More

Enanta Pharmaceuticals Annual EPS GAAP Estimates

Annual EPS GAAP Estimates Chart

View Annual EPS GAAP Estimates for ENTA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Annual EPS GAAP Estimates Data

View and export this data back to 2024. Start Trial.
Date Value
September 30, 2028 --
September 30, 2027 --
September 30, 2026 --
Date Value
September 30, 2025 --
September 30, 2024 --

Annual EPS GAAP Estimates Range, Past 5 Years

View Annual EPS GAAP Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Annual EPS GAAP Estimates Benchmarks

View Annual EPS GAAP Estimates Benchmarks
Start Trial
Perspective Therapeutics, Inc. Upgrade
Coherus Oncology, Inc. Upgrade
BridgeBio Pharma, Inc. Upgrade
RenovoRx, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade